Paradigm Biopharmaceuticals Limited
Save
54.71M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.

Similar securities

Based on sector and market capitalization

Report issue